Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 2/20 | 0.50 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | MGLL | Q99685 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 4/20 | 0.43 |
| ▸ | CRHBP | P24387 | 2/20 | 0.43 |
| ▸ | CRHR2 | Q13324 | 2/20 | 0.43 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.43 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.43 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12537417 | 0.91 | ALDH1A1 (0.49) | ALDH1A1HDAC3HDAC1HDAC2L3MBTL1 | |
| SCHEMBL8446208 | 0.91 | PRKCA (0.52) | PRKCAPRKCDHDAC3HDAC1HDAC2 | |
| SCHEMBL9721791 | 0.87 | PRKCA (0.61) | PRKCAPRKCDALDH1A1MAPTPNLIP | |
| SCHEMBL17077052 | 0.87 | ALDH1A1 (0.51) | ALDH1A1HDAC3HDAC1HDAC2L3MBTL1 | |
| SCHEMBL17083857 | 0.87 | ALDH1A1 (0.51) | ALDH1A1HDAC3HDAC1HDAC2L3MBTL1 | |
| SCHEMBL9979048 | 0.86 | LSS (0.43) | PRKCAPRKCDALDH1A1L3MBTL1ATM | |
| SCHEMBL17941247 | 0.85 | ALDH1A1 (0.50) | ALDH1A1HDAC3HDAC1HDAC2L3MBTL1 | |
| SCHEMBL15382426 | 0.85 | ALDH1A1 (0.52) | ALDH1A1HDAC3HDAC1HDAC2MGLL | |
| SCHEMBL29052458 | 0.84 | ALDH1A1 (0.52) | ALDH1A1HDAC3HDAC1HDAC2L3MBTL1 | |
| SCHEMBL260436 | 0.84 | ALDH1A1 (0.52) | ALDH1A1HDAC3HDAC1HDAC2L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020141081-A1 | PROCESS FOR SYNTHESIZING S-TRIAZINE COMPOUNDS | CLARIANT INTERNATIONAL LTD (CH) | 2020-07-09 | — | — | WO | disclosed |
| EP-3674293-A1 | PROCESS FOR SYNTHESIZING S-TRIAZINE COMPOUNDS | Clariant International Ltd (CH) | 2020-07-01 | — | — | EP | disclosed |
| US-8309715-B2 | Camphor-derived β-amino alcohol compounds, method for manufacturing the same and asymmetric addition of organozinc to aldehydes using the same | NATIONAL TSING HUA UNIVERSITY (TW) | 2012-11-13 | — | — | US | disclosed |
| CN-102516241-A | CNS active fused bicycloheterocycle substituted azabicyclic alkane derivatives | ABBOTT LAB | 2012-06-27 | — | — | CN | disclosed |
| US-20110313159-A1 | CAMPHOR-DERIVED BETA-AMINO ALCOHOL COMPOUNDS, METHOD FOR MANUFACTURING THE SAME AND ASYMMETRIC ADDITION OF ORGANOZINC TO ALDEHYDES USING THE SAME | NATIONAL TSING HUA UNIVERSITY (TW) | 2011-12-22 | — | — | US | disclosed |
| CN-101925599-A | Azabicyclic alkane derivatives as the biaryl substituted of nicotinic acetylcholine receptor activity modulators | ABBOTT LAB | 2010-12-22 | — | — | CN | disclosed |
| CN-101448825-A | CNS active fused bicyclic heterocycle substituted azabicycloalkane derivatives | ABBOTT LAB (US) | 2009-06-03 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110313159-A1 | CAMPHOR-DERIVED BETA-AMINO ALCOHOL COMPOUNDS, METHOD FOR MANUFACTURING THE SAME AND ASYMMETRIC ADDITION OF ORGANOZINC TO ALDEHYDES USING THE SAME | ADH1C, DDC, DCXR | PRKCA 113/4885PRKCD 68/4885ALDH1A1 216/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.